The document summarizes an upcoming Lean London Forum event on March 21, 2012 at the Royal College of Surgeons. The forum aims to share lean solutions in the NHS, engage in debate about lean's strengths and weaknesses, and network with colleagues. The agenda includes presentations on applying lean thinking in pathology and engaging primary care in pre-operative patient evaluation. It concludes with a hot seat question and answer session and networking reception.
University of Utah Health Exceptional Value Annual Report 2013University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
University of Utah Health Exceptional Value Annual Report 2016University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
University of Utah Health Exceptional Value Annual Report 2013University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
University of Utah Health Exceptional Value Annual Report 2016University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
Новость: в ВАО начала распространяться народная газета. Она так и называется — «Московская народная газета». Она совсем не похожа на те чиновничьи районные и окружные газеты, что вы получаете. Здесь пишут о реальной ситуации в восточном округе, а не о том, как глава управы постриг газон и поздравил пенсионеров.
http://socgrad.ru/org/redakciya_socgrada/blog/3759.html
Creating a workable solution to your client's problems is more than a mere technological challenge. In order to be relevant to your audience, your work must also connect with them on an emotional level. Because different audiences have different emotional needs, the visual design of your product is key to grabbing their attention and keeping them engaged.
This presentation was given at UnSummit4 on June 26, 2010, and was facilitated by Brock Ray and Brent Swanson, principles of Circadian, a Minneapolis-based design and branding firm.
Accelerating the translation of medical research - 27 JuneInnovation Agency
Slides from the event focusing on translational research in Liverpool and North of England and why companies are establishing and growing operations in the region.
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...GenesisCareUK
A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.”
ISS Service Innovation Leadership Seminar, 28 March - Mrs Chew Kwee TiangNUS-ISS
ISS Service Innovation Leadership Seminar, 28 March - "Design Thinking and Service Innovation - The Khoo Teck Puat Hospital's Journey" by Mrs Chew Kwee Tiang, CEO, Khoo Tech Puat Hospital
A joint presentation on Real People, Real Data at the 2016 International Forum on Quality and Safety in Healthcare in Gothenburg, Sweden. Presented by Leanne Wells of the Consumers Health Forum of Australia; Sam Vaillancourt of St. Michael’s Hospital, Toronto, Canada, and; Dr Paresh Dawda of the Australian National University.
Presentation by Dr Martin Myers MBE, PhD, FRCPath, Consultant Clinical Biochemist, Lancashire Teaching Hospitals NHS Foundation Trust at ECO 19: Care closer to home on Tuesday 9 July at Deepdale Stadium.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
1. Lean London Forum
21 March 2012
Royal College of Surgeons
For more information, please email help@leanlondon.org.uk or telephone 0207 824 8448
2. - 2 -
Confidential not to be used without consent
We have some broad aims of the forum
• Create the environment where Lean Solutions in the NHS
are shared, discussed and acted upon by practitioners in
the health service
• Engage in a debate about strengths and weakness of
lean in the current NHS climate
– The QIPP agenda in reducing costs across the health system
– Clinical Commissioning Groups that will redefine ‘end to end’ health systems
processes
• To network with colleagues and friends
3. - 3 -
Confidential not to be used without consent
Agenda
• 1800 - 1810 Welcome and introductions
• 1810 - 1835 The Path-ology to Lean Thinking - Dr Mathew Diggle &
Suzanne Horobin
• 1835 - 1900 Pre-operative health evaluation - engagement with Primary
Care - Dr Ahmed Chekairi, Whittington Hospital
• 1900 - 1930 Hot seat session
• 1930 - 2000 Networking and drinks
4. - 4 -
Confidential not to be used without consent
Introductions
• Your Name
• Your Role
• The one thing relating to
Lean you are curious about?
5. - 5 -
Confidential not to be used without consent
• Focus on Value from a Customer (Patient) point of view on every
step of process
• Obsession on removing waste within the ‘whole system’
• Bottom up approach in identifying value and waste – assumption
that much of waste and value is hidden
• A true lean system would “flow” and need little command and
control
Recap – What is Lean?
7. Background
• Diagnostic service: 24/7, 365 days per year
• Population served: >2.5 million
• Workload: 970,000 pa
• Isolation, identification and detection of
medically important bacteria,
viruses and parasites.
8. • Screening and specialist service:
expertise in biological agent
detection
• Clinical advice -on the diagnosis,
management & treatment of
infections, with regular ward rounds
on intensive care etc.
• Infection control- MRSA isolation and
Clostridium difficile toxin screening
Background
10. LEAN
• Perfected by Toyota – from 1928
• ‘Lean’ coined by Jones & Womack in 1990s
• Lean is about improving flow and eliminating waste
• getting the right things to the right place,
• at the right time,
• in the right quantities,
• while minimising waste and being flexible and open to change.
• Customer at heart of the process
• Driver for Quality and Safety
18. The Path-ology
• High Volume testing – Urines and MRSA screening
• Highly visible – Reception area
• Highly productive – What matters to me!
• Highly effective!
20. Results from Urines
Oct-11Sept-11Baselin
e Aug-
11
Oct-11Sept-11Baselin
e Aug-
11
Oct-11Sept-11Baselin
e Aug-
11
95.786.985.977.466.158.739.239.840.9
% reported within 48
hrs
% reported within 24
hrs
% reported day of
receipt
21. Results from Reception
Negative urines from PCTs:
Total time from receipt to authorisation
0.0
5.0
10.0
15.0
20.0
25.0
30.0
10:15
12:30
12:30
12:30
14:15
14:15
14:15
14:15
14:15
15:45
15:45
15:45
16:00
16:00
16:00
16:00
16:00
16:00
16:00
16:00
16:00
Time of receipt
Hours
Negative urines from hospital patients:
Total time from receipt to authorisation
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
09:15
09:15
10:00
10:30
10:30
10:30
11:00
11:45
13:00
14:15
14:15
14:15
14:15
15:30
16:30
16:30
16:30
Time of receipt
Hours
Most GP specimens’ turnaround time (TAT) <
5h (median=3.1h). Overnight storage results
in TAT c. 25h
Most in-patient specimens’ TAT <4h, but may
be as high as 7h (median=3.1h).
Negative urines from PCTs:
time from receipt to authorisation
0.0
5.0
10.0
15.0
20.0
25.0
09:00
12:30
12:45
12:45
14:00
14:00
14:30
14:30
15:30
15:30
16:15
16:15
16:15
16:15
16:30
16:30
16:30
Time of receipt
Hours
Then
Now
Negative urines from in-patients: time from receipt to
authorisation
0.0
1.0
2.0
3.0
4.0
5.0
09:00
09:00
09:45
10:30
10:30
10:30
10:30
11:00
13:00
14:00
14:00
14:00
15:00
16:15
16:30
Time of receipt
Hours
Most GP specimens’ turnaround time (TAT)
< 4h (median=1.7h). Overnight storage
results in TAT c. 20h
i.e. median TAT reduced by 45%
(mean TAT reduced by 29%)
Majority of in-patient specimens’ TAT<3h
(median=2.4h)
i.e. median TAT reduced by 23%
(mean TAT reduced by 23%)
Overall, TAT for all negative samples has
been reduced by 45% (median 3.1h to
1.7h)
Number of samples processed via UF100
increased by 11% on dates sampled.
24. Improved process
• Post-Lean, there is improved prioritisation of in-patient
samples, as the time from receipt to UF100 processing
has been reduced by 50% (median 0.8h to 0.4h) and time
from receipt to registration has been reduced by 25%
(median 0.8h to 0.6h).
• Removal of excessive checking (demo-checking) has
reduced the processing time for negative samples by 43%
(from 2.3h to 1.3h).
• Positive feedback from staff as process runs more
smoothly and calmly.
25. The Path - Key Challenges
• Maintaining momentum / energy / time
• Communication with all stakeholders
• Support laboratory staff and stakeholders
27. Who are NHS Improvement?
• DH partnership - aligned to support delivery of national strategies
and priorities - support QIPP Pathology Programme
• Key sponsors – Prof Sir Mike Richards, Prof Roger Boyle,
Dr Ian Barnes, Dr Erika Denton, Prof Sue Hill
• Over 10 years improvement experience, practical knowledge and
“how to” approach to improve quality and productivity
• Last 12 months – supported 240+ sites - improving Cancer,
Diagnostics, Heart, Lung and Stroke services
28. NHS Improvement - Diagnostics
• Proven success in Pathology
– 95% Histopathology results in 7 days, 50% in 3 days – Whipps Cross
– 100% Cytology results in 14 days, >50% in 7 days – Phase 1/2 pilot sites
– 50% improvement in Phlebotomy outpatient waiting times - Doncaster
– 90% reduction in Microbiology TAT – Stoke on Trent
– 43% reduction in Histopathology TAT – Calderdale & Huddersfield
– 62% reduction in Haematology TAT – St James Hospital
– 21% reduction of inappropriate demand urines – St Helens & Knowsley
• Improvements in safety and quality
• Increased capacity and space utilisation
• Improved staff engagement
• National Clinical Lead / Associate support
30. What’s the problem?
• University Hospitals Coventry and Warwick Cytology – 47%
forms missing sender code
• Hull and East Yorkshire Hospitals NHS Trust – 154 cytology
samples in 2 weeks received with errors
• Taunton & Somerset NHS Foundation Trust – Musgrove
Park Histopathology – 28% specimen receipt / data entry
errors
• Nottingham University Hospital NHS Trust – 8941
microbiology samples rejected due to defects (12.8%)
33. Sample Sorting
START
PatientReferral
Cycle time =
Batch Size =
Defects =
Trigger=
Insert the measurements - Gather real data
- this is your chance to really understand
what’s happening.
Defects – What
percentage is not
right first time and
requires further
work?
34. • Manual data collection
• One week
• Tick every error that occurs
• Capturing lab number will enable root
cause analysis later
• Errors as a % of total workload for the
week
38. Cost of poor quality - COPQ
Ideal – every case is booked in RIGHT FIRST TIME
•Dealing with a typical error requires a 5 minute search of the current laboratory
database followed by a 5 minute telephone call to find the correct information = 10
mins per error
•5% of cases have errors requiring this rework
•5% of annual workload of 50,000 samples = 2500
•Handling time 2500 samples x 10 minutes = 25000 minutes
•Or 416 hours
•Or 55.5 WORKING DAYS
•At midpoint Band 3 = £5170.88
This is the cost of poor quality
49. Does it really work?
• University Hospitals Coventry and Warwick Cytology – reduction in
errors reduced booking in time saving 1789 hours of office time per
annum (240 working days)
• Hull and East Yorkshire Hospitals NHS Trust – reduction in returned
samples freed up 10 hours per month
• Taunton & Somerset NHS Foundation Trust – Musgrove Park
Histopathology – errors down from 29% to 8% so far
• Nottingham University Hospital NHS Trust – 8941 microbiology samples
rejected due to defects (12.8%) – work in progress!
50.
51. Lean London
The Royal College of Surgeons
21 March 2012
Dr Ahmed CHEKAIRI
MD, FRCA, PGDip
Consultant Anaesthetist
Whittington Health, London
Pre-Operative Care
Assessment at Primary Care
52. Old Paradigm
• Pre-operative assessment is the process by which
patients who are booked in for an elective surgical
procedure undergo an anaesthetic assessment to
evaluate their fitness for surgery
56. New Pre-assessment Service
New Paradigm: Pre-Operative Health Evaluation and Optimisation
New Pre-assessment Service
New Paradigm: Pre-Operative Health Evaluation and Optimisation
New set up
•One stop clinic: Health evaluation on the day decision
to operate is made
•8000 travels/year less, More than 4000 patients
would go straight to surgery
•Standardised documentation with traffic light system,
triggers for right investigations and right referrals
•Improving patients’ safety by including checklists
alerts
•Criteria-based Decision making algorithms based on
best evidence and in response to National and
international Governance bodies
•Systematic risk stratification= better consent=better
planning=appropriate use of Intensive care
Promoting good health beyond surgery
•Pre assessment is Health MOT opportunity for
surgical patients
•Improving nutritional state pre-operatively and
at long-term
•Ensuring good diabetes and blood pressure
control & promoting smoking cessation and
sensible alcohol intake
Staff
•CPD programme for nurses
•Training programme for trainees
•Consultant anesthetists run clinics
•Continuous measurement
Future (near future)
•Connect and cooperate with GPs
•Align peri-operative goals between
Hospital and Primary care: ‘optimise as
you refer’
Benefits
•Active treatment of anaemia pre-operatively using
intra venous iron
•Right investigations (more than 20% unnecessary
investigations last year)
•Better diagnosis and more inclusive screening (Sleep
apnea and mental state screenings)
•Promoting day surgery and Enhanced Recovery Care
for all patients
•Systematic assessment of mobility = better post
operative planning
•Minimising cancellation on day
Systematic optimization of reversible conditions such as
diabetes ,HBP, infection & others
A patient story
G.H, a self-employed, attended the Pre
assessment service on 01/03/12. This was the
day of the new pre assessment service trial.
He was seen soon after surgeon told him
about the need for surgery.
Health evaluation revealed one medical
concern that required blood tests and an ECG.
These were done on the spot in POA clinic.
He was also seen by a Consultant anesthetist
at same visit.
Patient was advised of the risks of his
condition and the need for treatment at long
tem; he was also advised to contact his GP.
Then was given a suitable date for his surgery
Similar patients in the past would have been
added to the waiting surgical list and given 2
dates. One for surgery and another one for pre-
assessment. Time interval between the 2 dates
is variable. They may also have a 3rd date to
see an anaesthetist consultant.
G.H would have lost 3 working days as unpaid
leave even before getting his operation.
Better patient’s experience, Less travels to the Hospital, Better quality of care,
Less waste
Ahmed.chekairi@nhs.net for more information
57.
58.
59.
60. A patient story
G.H, a self-employed patient, attended the Pre assessment service on
01/03/12. This was the day of the new pre assessment service trial. He was seen soon
after surgeon told him about the need for surgery.
Health evaluation revealed one medical concern that required blood tests and an ECG.
These were done on the spot at POA clinic.
He was also seen by a Consultant anesthetist at same visit. Patient was advised of the
risks of his condition and the need for treatment at long tem; he was also advised to
contact his GP. Then he was given a suitable date for his surgery
Similar patients in the past would have been added to the waiting surgical list and given 2
dates. One for surgery and another one for pre-assessment. Time interval between the 2
dates is variable. They may also have a 3rd date to see an anaesthetist consultant.
G.H would have lost 3 working days as unpaid leave before getting his operation!
61. - 61 -
Confidential not to be used without consent
Your Questions on LeanYour Questions on Lean
What is the
impact on CCG
on end to end
transformation?
Can Lean fail?,
and for what
reason?
We have no
budget to start
Lean – what
can we do?
We have low
morale and no one
is willing to
change, what can I
do?
What the one thing
that makes the
biggest
difference?
62. - 62 -
Confidential not to be used without consent
What’s Next?
• Today’s presentation and feedback survey sent out by email within
48 hours
• The Next Lean London Forum will be held in September 2012.
– Register at www.leanlondon.org.uk
– We will send out reminders to all participants from today
– We have a Lean Midland Forum on 12 June 2012 taking place in Birmingham. Register
at www.leanmidland.org.uk
– If you’d like to take up one our presentation slots, please do let us know. We are keen
to hear from Community Trust and GP Groups
• Find us on Linked In and Twitter - LeanNHS
63. - 63 -
Confidential not to be used without consent
Big Thanks To Our Presenters
Suzanne Horobin
Mathew Diggle
Ahmed Chekairi
..and to you all for attending
64. - 64 -
Confidential not to be used without consent
Thanks to Our Sponsors
Assisting with Lean Transformations
in the health sector and beyond
www.kinetik.uk.com
www.leanexecutives.co.uk